RegenoGel, an advanced injectable gel for joint treatment, has been officially certified as a medical device by the Medical Devices Division (AMAR) of the Israel Ministry of Health, specifically for patients suffering from knee osteoarthritis.
This certification follows a series of rigorous pre-clinical and clinical trials, conducted in collaboration between Procore and the Orthopedic Department of Assaf Ha’Rofeh Medical Center. The clinical study involved patients with severe osteoarthritis, all of whom were scheduled for total knee replacement surgery.
This achievement marks an important milestone in the long-standing collaboration between Procore and leading orthopedic experts, under the leadership of Prof. Nachum Halperin and Dr. Gavriel Eger.
